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ihe Weasel Clause
xcluding Patients From
oor-to-Balloon Analyses
umerous broad-based studies, including that from the U.S.
ational Registry of Myocardial Infarction (1), have convincingly
hown a direct relationship between door-to-balloon time and
n-hospital mortality for patients treated with primary percutane-
us coronary intervention for ST-segment elevation myocardial
nfarction. Presumably, the principal reason for this observation is
hat ischemic time, and hence infarct size, is limited by early
eperfusion (2). Some data suggest, however, that the reduction in
ortality is due to greater overall quality of care rather than
eperfusion time per se (3).
Fast door-to-balloon times require a multidisciplinary system
pproach. This has been carefully studied and noted to include,
hen possible, paramedic electrocardiogram transfer to alert the
eceiving team, single-page activation of the on-call team, and a
uality control program with system feedback, all of which, to a
arge degree, are under control of the emergency medical services–
mergency room–interventional cardiology “system.” There are a
umber of factors that might adversely affect door-to-balloon time
hat are beyond the control of the team, including difficult consent
rocess, need to exclude serious comorbidities that might influence
oncomitant drug therapy for primary percutaneous coronary
ntervention (e.g., intracranial hemorrhage for a patient found
own and resuscitated), and cardiac arrest occurring between the
ime of emergency department arrival and initiation of percutane-
us intervention. Some other potential causes for delay are well
ithin the control of the interventionalist team, including
eekend/off-hours staffing, skillful vascular access, and rapid
annulation of the infarct-related artery.
Door-to-balloon-time metrics can be appropriately used both
or internal quality control and for external comparison. For
nternal quality control, the hospital might choose to exclude
atients with certain comorbidities, and as long as they are
onsistent in doing so, they can track improvements in outcome
nd even compare among operators. For external comparison,
owever, particularly in the “pay for performance” era, the exclu-
ion rules must be applied uniformly. Ideally, reasons for exclusion
hould not be subjective or easily “gamed.” Few, it would seem,
ould argue with these ground rules.
Therefore, when the most recent ACC NCDR-revised reasons
or patient exclusion in door-to-balloon time analysis were an-
ounced (4)—most notably difficult vascular access or difficulty in
rossing the culprit lesion, both highly subjective and easily used to
xplain a poor door-to-balloon time—it struck us as inappropriate.
n fact, when we heard these exclusions described, our initial
ommentary was “this would allow for an abrogation of responsi-
ility” or, more colorfully, “this is a weasel clause!” dPhysicians are under fire from multiple quarters due to per-
eived lack of integrity arising from the activities of some of our
olleagues. We call for a retraction of such subjective and easily
anipulated exclusions immediately. Should that not be possible,
r meet with illogical resistance, at a minimum, each site should be
equired to report the percentage of patients with ST-segment
levation myocardial infarction that were excluded from “report-
ble” door-to-balloon time.
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eply
s contributors to the NCDR (National Cardiovascular Data
egistry), we read the letter by Ellis and colleagues with interest.
he NCDR has long been dedicated to the measurement and
mprovement in care quality. Undoubtedly, these goals are best
romoted when the measures used to characterize quality are as
alid as possible.
We agree regarding the distinction between measures used for
he purposes of quality improvement and those intended for the
urposes of external accountability. Indeed, the American College
f Cardiology/American Heart Association (ACC/AHA) Perfor-
ance Measures Task Force methodology explicitly acknowledges
his dichotomy (1). Measures used for the purposes of account-
bility must rise to a particularly high standard with respect to
alidity, burden of data collection, and susceptibility to “gaming.”
The specific issue Ellis and colleagues raise is the exclusion in the
eperfusion measure for patient-centered reasons for delaying therapy
n the NCDR CathPCI Registry. Clinically appropriate reasons for
elays in reperfusion therapy are numerous. Indeed, enumerating
